Endogenous type-I interferon activity is not associated with depression or fatigue in systemic lupus erythematosus

被引：20

作者：

Kellner, Erinn S. ^{[1
,2
]}

Lee, Pui Y. ^{[1
,2
,3
]}

Li, Yi ^{[1
,2
]}

Switanek, Juliana ^{[1
,2
]}

Zhuang, Haoyang ^{[1
,2
]}

Segal, Mark S. ^{[1
,2
,3
]}

Sobel, Eric S. ^{[1
,2
,4
]}

Satoh, Minoru ^{[1
,2
,4
]}

Reeves, Westley H. ^{[1
,2
,4
]}

机构：

[1] Univ Florida, Div Rheumatol & Clin Immunol, Gainesville, FL 32610 USA

[2] Univ Florida, Ctr Autoimmune Dis, Gainesville, FL 32610 USA

[3] Univ Florida, Div Nephrol Hypertens & Transplantat, Gainesville, FL 32610 USA

[4] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA

来源：

JOURNAL OF NEUROIMMUNOLOGY | 2010年 / 223卷 / 1-2期

关键词：

Systemic lupus erythematosus; Depression; Fatigue; Type-I interferon; INDUCIBLE GENE-EXPRESSION; CHRONIC HEPATITIS-C; DISEASE-ACTIVITY; PSYCHIATRIC MANIFESTATIONS; COGNITIVE DYSFUNCTION; IFN-ALPHA; ANTIBODIES; SLE; ACTIVATION; RECEPTORS;

D O I：

10.1016/j.jneuroim.2010.03.018

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Patients with systemic lupus erythematosus (SLE) often suffer from depression and fatigue in addition to the physical manifestations of the autoimmune disease. Elevated production of type-I interferons (IFN-I) has been found in lupus patients and IFN-I can precipitate a variety of neuropsychiatric side effects. This study was conducted to evaluate the relationship between dysregulated IFN-I production and the presence of depression or fatigue in lupus patients. Through cross-sectional and longitudinal analysis we found no significant correlation between abnormal IFN-I levels (as measured by peripheral blood expression of IFN-I-stimulated genes) and neuropsychiatric manifestations. Elevation of endogenous serum IFN-I levels is unlikely to account for the depression and fatigue associated with SLE.

引用

页码：13 / 19

页数：7

共 50 条

[1] TYPE I INTERFERON ACTIVITY IS ASSOCIATED WITH MUCOCUTANEOUS BUT NOT MUSCULOSKELETAL DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS
Mohamed, A. A. A.
El-Sherbiny, Y.
Hensor, E. M.
Yusof, M. Y. Md
Goma, S. H.
Abda, E. A.
Abd-Allah, F. M.
Emery, P.
Vital, E.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 547 - 547
[2] Type I interferon in systemic lupus erythematosus
Crow, M. K.
INTERFERON: THE 50TH ANNIVERSARY, 2007, 316 : 359 - 386
[3] Type-I interferons and systemic lupus erythematosus
Koutouzov, Sophie
Mathian, Alexis
Dalloul, Ali
AUTOIMMUNITY REVIEWS, 2006, 5 (08) : 554 - 562
[4] Type I Interferon and Systemic Lupus Erythematosus
Elkon, Keith B.
Stone, Vivian V.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (11): : 803 - 812
[5] Type I interferon in the pathogenesis of systemic lupus erythematosus
Postal, Mariana
Vivaldo, Jessica F.
Fernandez-Ruiz, Ruth
Paredes, Jacqueline L.
Appenzeller, Simone
Niewold, Timothy B.
CURRENT OPINION IN IMMUNOLOGY, 2020, 67 : 87 - 94
[6] Targeting type I interferon in systemic lupus erythematosus
Timothy B. Niewold
Nature Reviews Rheumatology, 2016, 12 : 377 - 378
[7] Systemic lupus erythematosus and the type I interferon system
Lars Rönnblom
Gunnar V Alm
Arthritis Res Ther, 5
[8] The genetics of type I interferon in systemic lupus erythematosus
Bronson, Paola G.
Chaivorapol, Christina
Ortmann, Ward
Behrens, Timothy W.
Graham, Robert R.
CURRENT OPINION IN IMMUNOLOGY, 2012, 24 (05) : 530 - 537
[9] Type I Interferon Signature in Systemic Lupus Erythematosus
Bezalel, Shira
Guri, Keren Mahlab
Elbirt, Daniel
Asher, Ilan
Sthoeger, Zev Moshe
ISRAEL MEDICAL ASSOCIATION JOURNAL, 2014, 16 (04): : 246 - 249
[10] Systemic lupus erythematosus and the type I interferon system
Rönnblom, L
Alm, GV
ARTHRITIS RESEARCH & THERAPY, 2003, 5 (02) : 68 - 75

← 1 2 3 4 5 →